APA (7th ed.) Citation

Scioli, M. G., Coniglione, F., Greggi, C., Evangelista, L., Fiorelli, E., Savino, L., . . . Orlandi, A. (2023). Ascorbic acid reduces Ropivacaine-induced myotoxicity in cultured human osteoporotic skeletal muscle cells. BMC musculoskeletal disorders, 24(1), 576-11. https://doi.org/10.1186/s12891-023-06702-5

Chicago Style (17th ed.) Citation

Scioli, Maria Giovanna, et al. "Ascorbic Acid Reduces Ropivacaine-induced Myotoxicity in Cultured Human Osteoporotic Skeletal Muscle Cells." BMC Musculoskeletal Disorders 24, no. 1 (2023): 576-11. https://doi.org/10.1186/s12891-023-06702-5.

MLA (9th ed.) Citation

Scioli, Maria Giovanna, et al. "Ascorbic Acid Reduces Ropivacaine-induced Myotoxicity in Cultured Human Osteoporotic Skeletal Muscle Cells." BMC Musculoskeletal Disorders, vol. 24, no. 1, 2023, pp. 576-11, https://doi.org/10.1186/s12891-023-06702-5.